In this activity, a panel of experts discuss current methods for determining the HER2 status of gastric adenocarcinomas and/or gastroesophageal junction cancers and the implications of these findings on treatment selection in the first-line setting and beyond.
Upon completion of this activity, participants should be better able to:
Service Chief and Senior Staff, Gastrointestinal Oncology
H. Lee Moffitt Cancer Center
Professor, University of South Florida
Tampa, FL
Associate Professor, Department of Medicine, Section of Hematology & Oncology
Director, Interdisciplinary Gastrointestinal Oncology Program
Assistant Director, Translational Research, Comprehensive Cancer Center
University of Chicago Medical Center
Chicago, IL
Attending Pathologist
Memorial Sloan Kettering Cancer Center
Professor, Pathology
Will Cornell Medical College
New York, NY
Featured RMEI CE Activities
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources
